Rob Williams develops new methods, liaises with potential users and develops numerous PET/CT projects from scratch, some of which have resulted in high-level funding for the entire research community. He has continued to expand on developing the infrastructure, maintaining the procedure manuals, maintaining advanced life support qualifications and equipment, written complex database programs with multicenter access, and has performed the IT administration role of the imaging process servers, performed radiation audits, developed and performed advanced quality control, and assisted with symposia and multiple presentations. He coordinates all services and organizational entities related to the successful operation of the Unit, including the building and maintenance of relationships and ongoing interface with hospitals and universities, contractors, volunteers and students and benefactors. The Unit has significant influence in the terms of its technological capacity, investment and relevance to the identification of research leading to the development of longer-term therapeutic treatment of diseases such as Alzheimer’s. He has also engaged with researchers to develop new methodologies and prepare publications such as a blood pool imaging system or CT averaging for detailed images of objects or quantification methods of amyloid imaging using enhanced reconstruction methods.
Reported by 9News, Clinical Director of The Florey Professor Graeme Jackson was interviewed about the technology developed at the Australian Epilepsy project.
26 June 2025
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025
Dr Sicong Tu is excited about helping motor neurone disease (MND) patients gain a much better idea of their disease progression: “The focus of our network is on bridging the gap between leading Aust
28 May 2025
A new national-scale molecular-imaging network that aims to improve cancer imaging, dementia diagnosis and treatment, and new radiopharmaceuticals was launched Saturday at the annual meeting for Austr
26 May 2025
Rebecca V Robertson, Noemi Meylakh, Lewis S Crawford, Fernando A Tinoco Mendoza, Paul M Macey, Vaughan G Macefield, Kevin A Keay, Luke A Henderson
Read Publication
Joseph J. Bartlett, Catherine E. Davey, Leigh A. Johnston, Jinming Duan
Read Publication